CAH
60
2
ROK
67
5
NKE
33
2
SLG
62
-4
LNC
45
-4
CMI
67
4
JCI
61
-2
STI
31
19
BMY
61
-3
SHW
70
2
DRI
56
2
IP
70
-3
DOW
30
2
OI
43
-2
PDCO
30
-6
SE
60
-5
R
77
2
WDC
38
-3
PNR
74
5
IVZ
49
-3
CAH
60
2
ROK
67
5
NKE
33
2
SLG
62
-4
LNC
45
-4
CMI
67
4
JCI
61
-2
STI
31
19
BMY
61
-3
SHW
70
2
DRI
56
2
IP
70
-3
DOW
30
2
OI
43
-2
PDCO
30
-6
SE
60
-5
R
77
2
WDC
38
-3
PNR
74
5
IVZ
49
-3
Financhill
Back

4D Molecular Therapeutics Vs. ePlus Industry Stock Comparison

Sell
26

FDMT
4D Molecular Therapeutics

Last Price:
8.02
Seasonality Move:
57.95%
Sell
27

PLUS
ePlus

Last Price:
80.50
Seasonality Move:
20.86%
Sell
26
4D Molecular Therapeutics (FDMT) is a Sell

Is 4D Molecular Therapeutics a Buy, Sell or Hold?

  • The current 4D Molecular Therapeutics [FDMT] share price is $7.70. The Score for FDMT is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • FDMT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
ePlus (PLUS) is a Sell

Is ePlus a Buy, Sell or Hold?

  • The current ePlus [PLUS] share price is $80.03. The Score for PLUS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • PLUS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FDMT Stock Price Chart

What is 4D Molecular Therapeutics's stock price today?

  • The 4D Molecular Therapeutics share price today is $7.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FDMT is experiencing selling pressure, which indicates risk of future bearish movement.

PLUS Stock Price Chart

What is ePlus's stock price today?

  • The ePlus share price today is $80.03
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLUS is experiencing selling pressure, which indicates risk of future bearish movement.

FDMT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.69 Sell
Relative Strength Index (14 RSI): 28.62 Sell
Chaikin Money Flow: -470478 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.03 - 8.75) Sell
Bollinger Bands (100): (9.41 - 19.39) Sell

PLUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.37 Sell
Relative Strength Index (14 RSI): 28.12 Sell
Chaikin Money Flow: -371573 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (91.15 - 100.85) Sell
Bollinger Bands (100): (81.19 - 98.29) Sell

FDMT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.12 Sell
20-day SMA: 8.25 Sell
50-day SMA: 10.72 Sell
200-day SMA: 20.55 Sell
8-day EMA: 8.04 Sell
20-day EMA: 8.49 Sell
50-day EMA: 10.53 Sell
200-day EMA: 16.57 Sell

PLUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 93.25 Sell
20-day SMA: 94.97 Sell
50-day SMA: 95.27 Sell
200-day SMA: 83.59 Sell
8-day EMA: 92.26 Sell
20-day EMA: 94.28 Sell
50-day EMA: 94.05 Sell
200-day EMA: 84.44 Sell

4D Molecular Therapeutics Earnings Growth & FDMT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.25 per share, and a decrease next year of $0.49 per share.

ePlus Earnings Growth & PLUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.53 per share, and a decrease next year of $0.07 per share.

4D Molecular Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

ePlus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):